Breast Cancer Health Center

Tools & Resources

Font Size

Estrogen and progesterone receptor tests

When a breast biopsy shows that cancer is present, other tests are used to determine which treatment will be the most effective.

Estrogen and progesterone receptor (ER/PR) tests identify whether hormones affect the way the cancer grows. The hormones estrogen and progesterone stimulate the growth of normal breast cells and some breast cancers. Breast cancer cells that lack these receptors (ER-negative and PR-negative cancers) are much less likely to respond to treatment with such medicines as tamoxifen or aromatase inhibitors. ER/PR-positive tumors have these receptors and are more likely to respond to treatment with tamoxifen or aromatase inhibitors.

Recommended Related to Breast Cancer

Breast Cancer Awareness Month: Me and the Girls

"You have breast cancer." This year, nearly 250,000 women in the U.S. will hear those words. Last year, Zunilda Guzman was one of them. "I was devastated," says Guzman, 39. "I wanted the world to end." But Guzman, mother to a 9-year-old daughter, knew she couldn't let that happen. And neither did any of the other nine breast cancer survivors interviewed by WebMD as part of a special project for Breast Cancer Awareness Month. Their stories relay important messages about prevention, screening,...

Read the Breast Cancer Awareness Month: Me and the Girls article > >

The results of estrogen and progesterone receptor tests help your doctor decide whether to use hormone therapy to stop the cancer from growing.

By	Healthwise Staff
Primary Medical Reviewer	Joy Melnikow, MD, MPH - Family Medicine
Specialist Medical Reviewer	Douglas A. Stewart, MD - Medical Oncology
Last Revised	August 18, 2009

WebMD Medical Reference from Healthwise

Last Updated: August 18, 2009

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.